biotts recap from lsx world congress 2024

The LSX World Congress has come to an end, and what an incredible event it was! We had numerous insightful meetings, productive discussions, and valuable networking opportunities. A special highlight was Jan Hendriks’ presentation of ourMTC-Y technology and showcasing the latest advancements in our Insulin project. We extend our heartfelt thanks to everyone who attended […]

Read more

Join Biotts at SusHi Tech Tokyo 2024!

We are thrilled to continue our mission of educating the world about the groundbreaking potential of transdermal drug delivery and our innovative MTC-Y technology. This week, you can find us in Japan at the SusHi Tech Tokyo 2024 Global Startup Programme. This event brings together stakeholders, entrepreneurs, and investors from around the globe to promote […]

Read more

Biotts in media

At Biotts, we’re committed to pioneering advancements in biotechnology that revolutionize healthcare. Our innovative solutions have garnered attention in the media recently, highlighting our dedication to improving lives worldwide. Check out these insightful articles featuring interviews with our Chief Technology Officer, PaweÅ‚ Biernat: 1. “Is there no limit to the potential of transdermal drug delivery […]

Read more

Join Us at LSX in london- meet with our ceo

We’re thrilled to announce that at the end of April (29-30.04), we’ll be heading to London for the 10th LSX World Congress! This premier event unites specialists, investors, senior decision-makers, R&D leaders, and industry KOLs from the biopharma, medtech, and healthtech sectors worldwide. Join us at LSX and book a meeting with Jan Henk Hendriks, […]

Read more

FIRST EVER NONINVASIVE insulin – preclinical results

Managing diabetes effectively often involves regular insulin administration, which can be challenging for patients due to the need for frequent injections. That’s why we’re dedicated to providing patients with an alternative: fully noninvasive insulin through transdermal application. We’re excited to share our preclinical data from a rat study with you. Study design The study was […]

Read more

LEARN MORE ABOUT OUR CEO – JAN HENDRIKS IN USA LEADERS INTERVIEW

The USA Leaders magazine has featured our CEO, Jan Henk Hendriks, as one of the “10 most influential pharma leaders of 2024”! We encourage you to read this interesting article to get to know Biotts and Jan better! Click here to read the article!

Read more